-Dow Jones
Here’s How Analysts View Marvell Post Q4
Most analysts slashed their price targets on Marvell Technology Inc (NASDAQ:MRVL) post Q4 results. Wells Fargo analyst Gary Mobley lowered the price…
Related Posts
Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program
Novamind Inc. (OTCQB: NVMDF), a mental health company specializing in psychedelic medicine, has announced the launch of a new clinic located in downtown Salt Lake City specializing in integrative behavioral health and services for adults with substance use disorders.
Recap: bluebird bio Q2 Earnings
Shares of bluebird bio (NASDAQ:BLUE) moved higher by 0.9% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 852.78% year over year to ($3.43), which missed the estimate of ($3.19).
Sunrise New Energy JV Secures $26M Credit Facility
Sunrise New Energy Co Ltd (NASDAQ:EPOW) said its joint venture, Sunrise (Guizhou) New Energy Material Co Ltd, has received…